D-0294-2022 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

FDA drug recall D-0294-2022 was initiated by Teva Pharmaceuticals USA on Dec 16, 2021 and is designated Class II. Reason for recall: Subpotent The recall status is terminated (terminated Nov 4, 2022). Affected quantity: a) 86,790 and b) 25,416 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 29, 2021
Initiation Date
Dec 16, 2021
Termination Date
Nov 4, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 86,790 and b) 25,416 bottles

Product description

Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454

Reason for recall

Subpotent

Distribution pattern

nationwide

Code information

a) Lots, 35446365A, Exp 03/2022; 35447040A, Exp 08/2022 & 35447948B, Exp 03/2023. b) Lots 35446318B, Exp 05/2022 & 35447947A, Exp 03/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0294-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0294-2022. Report a data issue: hello@regdatalab.com.